Expertise in
20
conditions

Jan F. Tack-Jan Tack

KU Leuven
Leuven, VLG, BE 
Expertise in
20
conditions
KU Leuven
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Jan Tack-Jan Tack practices in Leuven, Belgium. Tack-Jan Tack is highly rated in 20 conditions, according to our data. Their top areas of expertise are Indigestion, Gastroparesis, Irritable Bowel Syndrome (IBS), Vagotomy, and Endoscopy.

Their clinical research consists of co-authoring 571 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

KU Leuven
Leuven, VLG, Belgium
Other Locations
3000, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Prucalopride Versus Placebo in Functional Dyspepsia With Delayed Gastric Emptying
Prucalopride Versus Placebo in Functional Dyspepsia With Delayed Gastric Emptying
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drug: Prucalopride
Study Phase: Phase 4
The Role of Mast Cells on Duodenal Permeability After Duodenal Acid Perfusion in Healthy Volunteers
The Role of Mast Cells on Duodenal Permeability After Duodenal Acid Perfusion in Healthy Volunteers
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Phase: Phase 4
The Effect of Corticotropin Release Hormone on Duodenal Markers and Gastric Sensorimotor Function in Healthy Volunteers
The Effect of Corticotropin Release Hormone on Duodenal Markers and Gastric Sensorimotor Function in Healthy Volunteers
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Phase: Phase 4
Phase 4 Study of Mirtazapine in Functional Dyspepsia Patients With Weight Loss
Phase 4 Study of Mirtazapine in Functional Dyspepsia Patients With Weight Loss
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drug: Mirtazapine
Study Phase: Phase 4
SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
Enrollment Status: Completed
Publish Date: January 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Pilot Study to Assess the Procedural Feasibility to Combine and Compare Dynamic Magnetic Resonance Imaging and an Isovolumetric Intragastric Balloon to Assess Gastric Contractility in Healthy Adults
A Pilot Study to Assess the Procedural Feasibility to Combine and Compare Dynamic Magnetic Resonance Imaging and an Isovolumetric Intragastric Balloon to Assess Gastric Contractility in Healthy Adults
Enrollment Status: Completed
Publish Date: September 30, 2021
Intervention Type: Device
Study Phase: Not Applicable
An Explorative, Randomized, Placebo-controlled, DB, Parallel-group Trial, to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Subjects With GERD & With Persistent Symptoms Despite Taking a Stable Dose of PPIs
An Explorative, Randomized, Placebo-controlled, DB, Parallel-group Trial, to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Subjects With GERD & With Persistent Symptoms Despite Taking a Stable Dose of PPIs
Enrollment Status: Terminated
Publish Date: June 10, 2021
Intervention Type: Drug
Study Phase: Phase 2
Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome
Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome
Enrollment Status: Completed
Publish Date: May 28, 2021
Intervention Type: Dietary supplement
Study Phase: Not Applicable
ANTERO-5: A Clinical Investigation of Gastric Motility in Adult Patients at Risk to Develop Postoperative Ileus Following Colorectal Surgery
ANTERO-5: A Clinical Investigation of Gastric Motility in Adult Patients at Risk to Develop Postoperative Ileus Following Colorectal Surgery
Enrollment Status: Terminated
Publish Date: February 10, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Sham and Cross-Over-Controlled Trial of Per-oral Endoscopic Pyloromyotomy (G-POEM) in Patients With Refractory Gastroparesis
A Randomized, Sham and Cross-Over-Controlled Trial of Per-oral Endoscopic Pyloromyotomy (G-POEM) in Patients With Refractory Gastroparesis
Enrollment Status: Completed
Publish Date: January 27, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
ANTERO-4: A Clinical Investigation of the Effects of Erythromycin on Gastric Motility, Assessed With the VIPUN Gastric Monitoring System in Healthy Adults
ANTERO-4: A Clinical Investigation of the Effects of Erythromycin on Gastric Motility, Assessed With the VIPUN Gastric Monitoring System in Healthy Adults
Enrollment Status: Terminated
Publish Date: August 12, 2020
Intervention Type: Drug, Device
Study Phase: Not Applicable
The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers: a Randomized, Single-blind, Placebo-controlled Study
The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers: a Randomized, Single-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: June 28, 2017
Intervention Type: Device, Dietary supplement
Study Phase: Not Applicable
View 12 Less Clinical Trials

571 Total Publications

Insulin-like peptide 5: a new key player in IBS with diarrhoea and bile acid malabsorption?
Insulin-like peptide 5: a new key player in IBS with diarrhoea and bile acid malabsorption?
Journal: Gut
Published: August 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tack-Jan Tack's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile